These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 666459)
1. Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle. Van Nueten JM; Van Beek J; Janssen PA Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):42-52. PubMed ID: 666459 [TBL] [Abstract][Full Text] [Related]
2. The vascular effects of flunarizine as compared with those of other clinically used vasoactive substances. Van Nueten JM; Van Beek J; Janssen PA Arzneimittelforschung; 1978; 28(11):2082-7. PubMed ID: 582911 [TBL] [Abstract][Full Text] [Related]
3. Selective abolition of Ca-dependent responses of smooth and cardiac muscles by flunarizine. Nakayama K; Kasuya Y Jpn J Pharmacol; 1980 Oct; 30(5):731-42. PubMed ID: 7206379 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries. Broekaert A; Godfraind T Eur J Pharmacol; 1979 Jan; 53(3):281-8. PubMed ID: 759205 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues. Van Nueten JM; Janssen PA Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):37-55. PubMed ID: 4746630 [No Abstract] [Full Text] [Related]
6. Differential effects of verapamil and flunarizine on epinephrine-induced vasoconstriction and on spontaneous vasomotion of arterioles in skeletal muscle in the rat in vivo. De Clerck F; Loots W; Voeten J; Janssen PA J Cardiovasc Pharmacol; 1989 Jan; 13(1):76-83. PubMed ID: 2468939 [TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
8. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker. De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365 [TBL] [Abstract][Full Text] [Related]
9. The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries. Godfraind T; Dieu D J Pharmacol Exp Ther; 1981 May; 217(2):510-5. PubMed ID: 7229987 [No Abstract] [Full Text] [Related]
11. [The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels]. Fleckenstein A; Grün G; Byon KY Minerva Med; 1975 May; 66(38):1827-37. PubMed ID: 1128823 [TBL] [Abstract][Full Text] [Related]
12. Selectivity of calcium antagonism and serotonin antagonism with respect to venous and arterial tissues. Van Nueten JM; Vanhoutte PM Angiology; 1981 Jul; 32(7):476-84. PubMed ID: 7247071 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the action of cinnarizine and papaverine. Broekaert A; Godfraind T Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):333. PubMed ID: 677966 [No Abstract] [Full Text] [Related]
14. Inhibition by Cd2+ verapamil and papaverine of Ca2+-induced contractions in isolated cerebral and peripheral arteries of the dog. Hayashi S; Toda N Br J Pharmacol; 1977 May; 60(1):35-43. PubMed ID: 884389 [TBL] [Abstract][Full Text] [Related]
15. Comparative studies on the effects of the nootropic drug adafenoxate and of the cerebral vasodilator flunarizine on arterial smooth muscles. Todorov S; Petkov V Acta Physiol Pharmacol Bulg; 1988; 14(3):10-6. PubMed ID: 3146886 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the Ca2+-antagonistic activity of some Bulgarian vasodilating agents and of known Ca2+-antagonists on K+-depolarized smooth muscle from guinea-pig taenia coli. Mutafova-Yambolieva V; Staneva-Stoytcheva D; Nikolov R Acta Physiol Pharmacol Bulg; 1989; 15(2):40-6. PubMed ID: 2801147 [TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on the basic Ca2+ antagonistic activities of niludipine (Bay a 7168) and nifedipine (Bay a 1040) on the myocardium, myometrium and vessels of smooth muscles (author's transl)]. Fleckenstein A; Fleckenstein-Grün G; Byon YK; Haastert HP; Späh F Arzneimittelforschung; 1979; 29(2):230-46. PubMed ID: 582136 [TBL] [Abstract][Full Text] [Related]
18. Alternative mechanisms for the potentiation of the relaxation evoked by isoprenaline in aortae from young and aged rats. Godfraind T Eur J Pharmacol; 1979 Jan; 53(3):273-9. PubMed ID: 759204 [TBL] [Abstract][Full Text] [Related]
19. Time course of the effect of flunarizine on rabbit isolated vascular muscle. Wadsworth RM; Moss JP Eur J Pharmacol; 1982 Nov; 85(2):207-9. PubMed ID: 7151868 [TBL] [Abstract][Full Text] [Related]
20. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation]. Kubo K; Karasawa A; Yamada K; Nito M; Shuto K; Nakamizo N Nihon Yakurigaku Zasshi; 1982 May; 79(5):383-400. PubMed ID: 7129248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]